Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Silicone Hydrogel and Bausch and Lomb Contact Lens Prescribers: Ophthalmologists and Optometrists (US)

Steve Rubinstein, OD, Optometrist
Steve Rubinstein, OD, Optometrist
Sound Shore Vision Care
Analysis of: CooperVision Introduces Avaira™ Two-Week Silicone Hydrogel Contact Lenses (www.coopervision.com)
Can Cooper take over the 2 week spherical contact lens market? Can it make a dent in the market share of the industry leader in the silicone hydrogel field? Initial results look good. A definite maybe!
Analysis of: LASIK Worries? Some May See Better with Alternatives (www.washingtonpost.com)
The FDA report and scrutiny of LASIK complaints reveals what consientious LASIK surgeons have known for years:  Not everyone who walks through your doors is a good lasik candidate and you should not laser everyone.  About 1 out of 4 patients that consider lasik are actually good candidates...
Gary Barker, Partner/Owner
Gary Barker, Partner/Owner
Eye Associates Of Winter Park
Analysis of: LASIK Worries? Some May See Better with Alternatives (www.washingtonpost.com)
I welcome the FDA investigation of LASIK, as thousands of patients are undergoing the elective cosmetic procedure, with some achieving less than optimum results.  Will the study show that LASIK is not safe, or will it show that LASIK is not the real issue, rather that patient selection is...
Analysis of: CooperVision Introduces Avaira™ Two-Week Silicone Hydrogel Contact Lenses (www.coopervision.com)
Silicone Hydrgol lenses are the latest technology in the contact lens industry.  Nearly 100% of of my new fits are silicone hydrogel lenses, and the 2 week modality is the most popular wearing schedule. Currenly J&J has the lion's share of the market with their Acuvue Advance and Oasys contact...
Gary Barker, Partner/Owner
Gary Barker, Partner/Owner
Eye Associates Of Winter Park
Analysis of: Injectable glaucoma drug shown to reduce IOP in clinical study (www.osnsupersite.com)
Any new efficacious glaucoma treatment is welcome and needed, but patient compliance remains a factor.  A single injection treatment that provides IOP reduction for 3 months would greatly improve success in IOP control.  I would, however, like to see a lower target pressure set for the...
Gary Barker, Partner/Owner
Gary Barker, Partner/Owner
Eye Associates Of Winter Park
Analysis of: Novartis to buy Nestle's Alcon stakes for $39 billion (www.wtnzfox43.com)
The purchase of a controlling interest in Alcon by Novartis is a brilliant move by Novartis.  To bring the leading contact lens disinfectant together with Ciba's contact lenses is a wonderful marketing opportunity for Ciba.
Steve Rubinstein, OD, Optometrist
Steve Rubinstein, OD, Optometrist
Sound Shore Vision Care
Analysis of: Novartis and Nestlé in a Deal for Alcon (select.nytimes.com)
Alcon becomes part of a larger group that is very interested in profiting from eye care. The patient will probably not see any changes in labeling or distribution for a few years. The companies interlock well, but do not have a lot of overlap.....except for sales reps!
Analysis of: Pilot trial for toric correction with light-adjustable lens yields promising early results (ophthalmologytimes.modernmedicine.com)
The light adjustable lens is a lens implant that is placed in the eye like a tradition intraocular lens during cataract surgery.  The unique difference is that it can be treated with a special light after surgical implant (weeks to months later) to correct any residual refractive errors or to fine...
Analysis of: Contact lenses: A winning option for you and young patients (ecp.acuvue.com)
Contacts can successfully be worn with pediatric patinets as early as 10 years of age.  With that being said, patient selection is crucial.  You may encounter 10 year old patients that are as responsible as 7 year olds and vice versa.
Analysis of: Biovitrum has Completed an Exploratory Clinical Phase II Study in Glaucoma (www.pipelinereview.com)
Biovitrum may have discovered a new adjunct to our existing prostaglandin analogs.  Currently, the prostaglandins generally lower patients pressures by 30-40% therefore making them first line therapy.  If this new 5-HT2A drug can lower pressure an additional 10%, this drug would find a home...

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 Next11 to 20 of 110

Analytics


Generated at 2009-01-09T13:00:20.343